An Exploratory Sub-study for the RED-HF™ (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial

NCT00534456 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

12

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated

Conditions

Anemia
Cardiovascular Disease
Congestive Heart Failure
Heart Failure
Ventricular Dysfunction

Interventions

DRUG: Placebo
DRUG: Darbepoetin alfa

Sponsor

Amgen